[en] Although drug discovery efforts have drastically evolved over the past decades, the budget to bring a lead compound to successful FDA-approval has enormously increased and the number of new drugs continued to stagnate. One of the reasons is that most efforts have largely focused on well-known drug binding sites from five functional target families: enzymes, GPCRs, ion channels, nuclear receptors and transporters1. Most members of these families play key roles in normal and dysfunctional biological processes but their corresponding binding pockets are highly similar, making selective inhibition more challenging2. However, a wealth of other cavities exists on protein surfaces and could be exploited to selectively perturb key functionalities of a target while leaving the others intact3.
To identify chemicals capable of binding different cavities in a multi-subunit histone deacetylase (HDAC) complex, we have implemented an unbiased phenotypic screening approach and dissected the targeted machinery into its fundamental parts. After screening ~55,000 drugs from 9 diverse libraries, we have isolated 59 primary hits for which the impact on the HDAC complex was compared to that of subunit deletions. Interestingly, except for a handful of compounds, the inhibition profiles were very different than that for deletions, suggesting divergent mechanisms of action. Among the fraction of divergent candidates, we identified 4 compounds that were capable of inhibiting specific binary protein-protein interactions (PPIs) between known subunits of the complex. These compounds were also validated in orthogonal PPI assays and did not perturb HDAC enzyme activity, suggesting they might be true functional inhibitors of binary PPIs.
Our findings support the use of unbiased phenotypic approaches to identify functional inhibitors capable of binding under-explored cavities, such as those involved in PPIs, that will potentially lead to the development of new drugs and more targeted therapies.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Olivet, Julien ; Harvard University > Genetics > Dana-Farber Cancer Institute Center for Cancer Systems Biology > Visiting PhD student
Language :
English
Title :
Systematic assessment of druggable cavities in a histone deacetylase complex
Publication date :
05 March 2019
Number of pages :
36"x39"
Event name :
Phenotypic Drug Discovery: Recent Advances and Insights from Chemical and Systems Biology (C1)
Event organizer :
Keystone Symposia on Molecular and Cellular Biology (Mark Mercola, Fabien Vincent, Monica Schenone and Arsenio Nueda)
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.